Ian Glaspole
Overview
Explore the profile of Ian Glaspole including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
3417
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lough G, Abdulqawi R, Amanda G, Antoniou K, Azuma A, Baldi M, et al.
ERJ Open Res
. 2025 Mar;
11(2).
PMID: 40040894
Background: Suspected interstitial lung disease (ILD) patients may be referred to an ILD-specialist centre or a non-ILD-specialist centre for diagnosis and treatment. Early referral and management of patients at ILD-specialist...
2.
Donnan M, Ellis S, Glaspole I
Respir Med Case Rep
. 2024 Oct;
52:102123.
PMID: 39398874
Hermansky-Pudlak Syndrome is a rare genetic cause of pulmonary fibrosis, associated with albinism, nystagmus, and a bleeding diathesis. Histologically, Hermansky-Pudlak Syndrome Pulmonary Fibrosis (HPS-PF) typically resembles usual interstitial pneumonia (UIP),...
3.
Li A, Teoh A, Troy L, Glaspole I, Wilsher M, de Boer S, et al.
Thorax
. 2024 Sep;
79(11):1024-1032.
PMID: 39317451
Background: Lung function testing remains a cornerstone in the assessment and management of interstitial lung disease (ILD) patients. The clinical implications of the Global Lung function Initiative (GLI) reference equations...
4.
Lee J, Tikellis G, Hoffman M, Mellerick C, Symons K, Bondarenko J, et al.
PEC Innov
. 2024 Sep;
5:100328.
PMID: 39247403
Background And Objective: There is currently no self-management package designed to meet the needs of people with pulmonary fibrosis (PF). This study evaluated the feasibility and acceptability of a PF-specific...
5.
Donnan M, Siemienowicz M, Tay H, McLean C, Philpot S, Mason C, et al.
Respirol Case Rep
. 2024 Jul;
12(7):e01434.
PMID: 39015482
Trimethoprim-sulfamethoxazole (TMP-SMX) acute respiratory distress syndrome (ARDS) is a rare, but severe complication of a commonly prescribed antibiotic. TMP-SMX typically affects young, otherwise well patients with a specific human leukocyte...
6.
Holland A, Woollett A, Goh N, Glaspole I
Respirology
. 2024 Jun;
29(8):659-661.
PMID: 38924193
No abstract available.
7.
Koshy K, Barnes H, Farrand E, Glaspole I
Respirology
. 2024 Jun;
29(9):795-802.
PMID: 38825348
Background And Objective: Evidence for the benefit of steroid therapy in acute exacerbations (AEs) of idiopathic pulmonary fibrosis (IPF) is limited; however, they remain a cornerstone of management in other...
8.
Mackintosh J, Keir G, Troy L, Holland A, Grainge C, Chambers D, et al.
Respirology
. 2024 Jan;
29(2):105-135.
PMID: 38211978
Idiopathic pulmonary fibrosis (IPF) is a progressive disease leading to significant morbidity and mortality. In 2017 the Thoracic Society of Australia and New Zealand (TSANZ) and Lung Foundation Australia (LFA)...
9.
Hoffman M, Burge A, Wong N, McDonald C, Chambers D, Glaspole I, et al.
Chest
. 2023 Sep;
165(3):632-635.
PMID: 37659620
No abstract available.
10.
Zheng Q, Cox I, Leigh L, de Graaff B, Johnston F, Corte T, et al.
Respirology
. 2023 Jul;
28(10):916-924.
PMID: 37433646
Background And Objective: Little is known about the association between ambient air pollution and idiopathic pulmonary fibrosis (IPF) in areas with lower levels of exposure. We aimed to investigate the...